Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  American Journal of Obstetrics and Gynecology

• Publication date

  1994-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9378(94)90104-XPMID 8092235
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognosis for pre-eclampsia complicated by 5 g or more of proteinuria in 24 hours.

  1992cited by this paper
• Nifedipine pharmacokinetics and pharmacodynamics during the immediate postpartum period in patients with preeclampsia.

  1991cited by this paper
• Management of preeclampsia.

  1991cited by this paper
• Nifedipine in the Treatment of Severe Preeclampsia

  1991cited by this paper
• Aggressive or Expectant Management for Patients With Severe Preeclampsia Between 28–34 Weeks' Gestation: A Randomized Controlled Trial

  1990cited by this paper
• The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing?

  1990cited by this paper
• The use of nifedipine during the postpartum period in patients with severe preeclampsia.

  1990cited by this paper
• A protocol for managing severe preeclampsia in the second trimester.

  1990cited by this paper
• Outcome of pregnancies complicated by severe hypertension and delivered before 34 weeks; stepwise logistic regression analysis of prognostic factors

  1989cited by this paper
• Magnesium Plus Nifedipine: Potentiation of Hypotensive Effect in Preeclampsia?

  1988cited by this paper
• Fetal and neonatal outcome in patients with severe pre-eclampsia before 34 weeks.

  1987cited by this paper
• Ultrasound Assessment of the Postmature Pregnancy

  1985cited by this paper
• Pregnancy Outcome in 303 Cases With Severe Preeclampsia

  1984cited by this paper
• The Management of Severe Toxemia in Patients at Less than 36 Weeks' Gestation

  1979cited by this paper
• The management of severe toxemia in patients at less than 36 weeks' gestation.

  1979cited by this paper
• A standard of fetal growth for the United States of America.

  1976cited by this paper

• Early-onset preeclampsia: gestational age threshold of potential benefits.

  2026cites this paper
• Comparative study of fetomaternal outcome in patients with pregnancy-induced hypertension with and without hemolysis, elevated liver enzymes, and low platelets syndrome: a tertiary care center study

  2025cites this paper
• Pregnancy prolongation following diagnosis of pre‐eclampsia with severe features remote from term

  2025cites this paper
• Preeclampsia trials that changed practice.

  2025cites this paper
• Endothelial Nitric Oxide synthase (eNOS) in Preeclampsia: An Update.

  2024cites this paper
• Non-severe hypertensive disorders of pregnancy and oral antihypertensive medications: An argument in favor of use: Treatment of Gestational Hypertension.

  2024cites this paper
• PERINATAL AND MATERNAL OUTCOME OF PREECLAMPSIA WITH SEVERITY FEATURE MANAGED EXPECTANTLY AT ST. PAUL’S HOSPITAL MILLENNIUM MEDICAL COLLEGE (SPHMMC), 2021, ADDIS ABABA, ETHIOPIA. A CROSS SECTIONAL STUDY

  2024cites this paper
• Assessing Severity and Need for Delivery in Early Onset Preeclampsia Before 32 Weeks of Gestation: a Delphi Consensus Procedure

  2024cites this paper
• Hypertensive Disorders of Pregnancy: Diagnosis, Management and Timing of Birth

  2024cites this paper
• Hypertension Management in Pregnancy.

  2024cites this paper
• The Roles of Obesity and ASB4 in Preeclampsia Pathogenesis

  2024cites this paper
• Notfälle in der Schwangerschaft und Notfallgeburt

  2024cites this paper
• Non-severe hypertensive disorders of pregnancy and oral antihypertensive medications: An argument against use.

  2024cites this paper
• Review of Laboratory Testing and Biomarker Screening for Preeclampsia

  2024cites this paper
• Pregnancy Outcomes of Conservative Management in Preeclampsia with Severe Features

  2023influential citation
• Caring for two in the ICU: Pharmacologic management of pregnancy‐related complications

  2023cites this paper
• Frequency of Low Birth Weight in Patients with Gestational Hypertension

  2023cites this paper
• Utility of sFtl-1 and Placental Growth Factor Ratio for Adequate Preeclampsia Management

  2023cites this paper
• Administration of Antenatal Corticosteroids: Optimal Timing

  2023cites this paper
• A bibliometric review of 35 years of studies about preeclampsia

  2023cites this paper
• Aggressive Versus Expectant Management of Preeclampsia with severe features Remote from Term (24-34 weeks)

  2023influential citation
• Hipertensión y embarazo: revisión de la literatura

  2023cites this paper
• Prediction of Delivery Within 7 Days After Diagnosis of Early Onset Preeclampsia Using Machine-Learning Models

  2022cites this paper
• Quantifying the Additional Maternal Morbidity in Women with Preeclampsia with Severe Features in whom Immediate Delivery is Recommended.

  2022cites this paper
• Association of Maternal Medical Comorbidities with Duration of Expectant Management in Patients with Severe Preeclampsia

  2022cites this paper
• Hypertensive Disorders of Pregnancy: Common Clinical Conundrums

  2022cites this paper
• Síndromes hipertensivos del embarazo: pautas actualizadas para la conducta clínica

  2022cites this paper
• Gestational Hypertension and "Severe" Disease: Time for a Change.

  2022cites this paper
• Preeclampsia diagnosis and management.

  2022cites this paper
• Preeclampsia: state of art and future perspectives. A special focus on possible preventions

  2022cites this paper
• Manejo expectante en preeclampsia severa remota del término (24-33,6 semanas): experiencia en centro de alta complejidad

  2022cites this paper
• Pregnancy hypertension: An international journal of women's cardiovascular health.

  2021cites this paper
• Therapeutic plasma exchange and dextran‐sulfate plasma adsorption as extracorporeal treatments of extremely preterm preeclampsia with fetal growth restriction

  2021cites this paper
• Expectant Versus Interventionist Care in the Management of Severe Preeclampsia Remote from Term: A Systematic Review

  2021cites this paper
• Hypertensive Disorders of Pregnancy.

  2021cites this paper
• Amount of Proteinuria and Duration of Expectant Management in Severe Preeclampsia

  2021cites this paper
• Maternal and Neonatal Outcomes in Expectant Management of Early-Onset Severe Preeclampsia

  2021cites this paper
• Incidence and risk factors for severe preeclampsia, HELLP syndrome and eclampsia at preterm and term gestation: a population-based study.

  2021cites this paper
• Development of a Third Trimester Contingent Prognostic Prediction Scheme for Suspected Early-Onset Pre-Eclampsia

  2021cites this paper
• HELLP Syndrome Diagnostic and Management Approach, Literature Review

  2021cites this paper
• Immediate versus delayed induction of labour in hypertensive disorders of pregnancy: a systematic review and meta-analysis

  2020cites this paper
• Fetal Growth and Growth Restriction

  2020cites this paper
• Multiple Gestations and Hypertensive Disorders of Pregnancy: What Do We Know?

  2020cites this paper
• Hypertensive Disorders of Pregnancy.

  2020cites this paper
• Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin Summary, Number 222.

  2020cites this paper
• Severe preterm preeclampsia: an examination of outcomes by race.

  2020cites this paper
• Maternal complications of hypertension in pregnancy – A five year study

  2020cites this paper
• Expectant Management of Severe Pre-eclampsia remote from term: Maternal and Perinatal outcome

  2020cites this paper
• Temporizing management vs immediate delivery in early‐onset severe preeclampsia between 28 and 34 weeks of gestation (TOTEM study): An open‐label randomized controlled trial

  2020cites this paper
• Latency of preterm hypertensive disorders of pregnancy and subsequent cardiovascular complications.

  2020cites this paper
• A STUDY ON IV LABETALOL VERSUS ORAL NIFEDIPINE IN ACUTE CONTROL OF SEVERE HYPERTENSION IN PREGNANCY

  2020cites this paper
• Outcomes before and after Adopting Guidelines for Expectant Management of Severe Preeclampsia

  2020cites this paper
• sFlt-1/PlGF ratio for the prediction of delivery within 48 hours and adverse outcomes in expectantly managed early-onset preeclampsia.

  2020cites this paper
• Hypertension in Pregnancy

  2020cites this paper
• Added prognostic value of longitudinal changes of angiogenic factors in early‐onset severe pre‐eclampsia: a prospective cohort study

  2020cites this paper
• Adverse maternal and neonatal outcomes among women with preeclampsia with severe features <34 weeks gestation with versus without comorbidity.

  2020cites this paper
• Maternal and perinatal outcome of preeclampsia without severe feature among pregnant women managed at a tertiary referral hospital in urban Ethiopia

  2020cites this paper
• Retrospective evaluation of established cut-off values for the sFlt-1/PlGF ratio for predicting imminent delivery in preeclampsia patients.

  2020cites this paper
• A systematic scoping review of clinical indications for induction of labour

  2020cites this paper
• Pregnancy and Kidney Disease

  2020cites this paper
• Added prognostic value of longitudinal changes of angiogenic factors in early-onset severe preeclampsia: analysis of maternal outcomes.

  2020cites this paper
• Standardising definitions for the pre-eclampsia core outcome set: A consensus development study.

  2020cites this paper
• Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222.

  2020cites this paper
• Society for Maternal-Fetal Medicine (SMFM) Consult Series #50: The role of activity restriction in obstetric management.

  2020cites this paper
• Conservative management of early-onset severe preeclampsia: comparison between randomized and observational studies a systematic review

  2020cites this paper
• ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia.

  2019cites this paper
• Association of plasma lactate concentration at admission of severe preeclampsia to maternal complications.

  2019cites this paper
• Expectant Management of Hypertensive Disorders of Pregnancy and Future Cardiovascular Morbidity.

  2019cites this paper
• The Preeclampsia intervention with Esomeprazole (PIE) trial: A double blind, randomised, placebo-controlled trial to treat early onset severe preeclampsia

  2019cites this paper
• Expectant or outpatient management of preeclampsia before 34 weeks: safe for mother but associated with increased stillbirth risk

  2019cites this paper
• Efficacy of expectant management of severe preeclampsia and preeclampsia superimposed on chronic hypertension before 34 weeks gestation.

  2019cites this paper
• Are maternal and neonatal outcomes different in placental abruption between women with and without preeclampsia?

  2019cites this paper
• Preeclampsia outcomes at delivery and race

  2019cites this paper
• Endothelin receptor antagonism during preeclampsia: a matter of timing?

  2019cites this paper
• Comparison Of Mother’s Risk Factor, Mother And Baby Outcomes In Early-Onset Preeclampsia And Late Onset Pre-Eclampsia In 11 Hospitals In West Java

  2019cites this paper
• Endocrine Diseases of Pregnancy

  2019cites this paper
• Clinical Management Guidelines for Obstetrician – Gynecologists

  2019cites this paper
• Top‐cited articles in the Journal: a bibliometric analysis

  2019cites this paper
• Re-evaluation of abruptio placentae and other maternal complications during expectant management of early onset pre-eclampsia.

  2019cites this paper
• Placental effects and transfer of sildenafil in healthy and preeclamptic conditions

  2019cites this paper
• Outcome Comparison of Pregnancy Termination on 34th and 37th Week of Pregnancy among Patients with Severe Preeclampsia

  2019cites this paper
• Current and emerging pharmacotherapy for emergency management of preeclampsia

  2019cites this paper
• مراقبت مداخلهگرانه در مقابل مراقبت انتظاری برای پرهاکلامپسی شدید بین هفتههای 24 و 34 بارداری

  2018cites this paper
• Hypertensive Disorders in Pregnancy.

  2018cites this paper
• Beneficial effects of nicotinamide on the mouse model of preeclampsia

  2018cites this paper
• Hypertensive disorders of pregnancy

  2018cites this paper
• Hypertensive Disorders during Pregnancy

  2018cites this paper
• Comparison of intravenous magnesium sulphate versus placebo in the management of women with severe pre-eclampsia.

  2018cites this paper
• Complications of Preeclampsia

  2018cites this paper
• SEVERE PRE ECLAMPSIA: INTRAUTERINE GROWTH RESTRICTION AND PERINATAL OUTCOME IN PRETERM GESTATIONS

  2018influential citation
• Hypertensive disorders of pregnancy

  2018cites this paper
• Preeclampsia: risk factors and neonatal outcomes associated with early- versus late-onset diseases

  2018cites this paper
• Ishodi trudnoća nakon teške preeklampsije

  2018cites this paper
• A Study to Compare the Risks and Benefits of Aggressive Management with the Expectant Management for Women With Severe Preeclampsia between 28 and 36 Weeks Admitted in Burdwan Medical College and Hospital

  2018cites this paper
• Interventionist versus expectant care for severe pre-eclampsia between 24 and 34 weeks' gestation.

  2018cites this paper
• Serie guías clínicas: manejo de la preeclampsia (actualización)

  2018cites this paper
• Hypertension and pregnancy: expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology

  2017cites this paper
• Development and validation of Prediction models for Risks of complications in Early-onset Pre-eclampsia (PREP): a prospective cohort study.

  2017cites this paper
• The Roles of Metformin and Pravastatin on Placental Endoplasmic Reticulum Stress and Placental Growth Factor in Human Villous-Like Trophoblastic BeWo Cells

  2017cites this paper
• ACOG practice bulletin: Clinical management guidelines for obstetrician-gynecologists

  2017cites this paper